On the other hand, targeted deletion of the 9p21 non-coding interval in mice provided direct evidence that the risk interval has a pivotal role in regulation of cardiac CDKN2A/B expression, and suggested that this region affects CAD progression by altering the dynamics of vascular cell proliferation [38]. The gene discussed is CDKN2A; the disease is coronary artery disorder.